Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision.

Fratoni, Andrew J; Nicolau, David P; Kuti, Joseph L

Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision.

Fratoni, Andrew J; Nicolau, David P; Kuti, Joseph L.

Afiliação

Fratoni AJ; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Nicolau DP; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Kuti JL; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.

J Antimicrob Chemother ; 77(1): 164-168, 2021 12 24.

Article em En | MEDLINE | ID: mdl-34542637

Assuntos

Levofloxacino; Stenotrophomonas maltophilia; Animais; Antibacterianos/farmacologia; Antibacterianos/uso terapêutico; Humanos; Levofloxacino/farmacologia; Levofloxacino/uso terapêutico; Camundongos; Testes de Sensibilidade Microbiana; Coxa da Perna/microbiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Stenotrophomonas maltophilia / Levofloxacino Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google